Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
May 23, 2013 16:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 23, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
May 09, 2013 16:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports First Quarter 2013 Financial Results
April 30, 2013 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of First Quarter 2013 Financial Results Conference Call and Webcast
April 09, 2013 16:15 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
February 25, 2013 16:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2012 Financial Results
February 15, 2013 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 15, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2012.
For the...
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
February 07, 2013 09:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2012 Financial Results Conference Call and Webcast
January 24, 2013 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals to Present at the Deutsche Bank 2012 dbAccess BioFEST
November 27, 2012 16:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 27, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in "Safe-Harbor" Case
November 20, 2012 12:41 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...